Finance

Lists
DVAI34:BVMF
Davita Inc BDR
893,56 R$
0,00%
(0,00) 1D
9 ოქტ, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DVAI34...
Open
893,56 R$
High
893,56 R$
Low
893,56 R$
Mkt. cap
11,44 მლრდ.
Avg. vol.
7,00
Volume
1,00
52-wk high
1 253,26 R$
52-wk low
546,63 R$
Shares outstanding
63,80 მლნ.
No. of employees
78 ათ.
Open
893,56 R$
High
893,56 R$
Low
893,56 R$
Mkt. cap
11,44 მლრდ.
Avg. vol.
7,00
Volume
1,00
52-wk high
1 253,26 R$
52-wk low
546,63 R$
Shares outstanding
63,80 მლნ.
No. of employees
78 ათ.
News stories
From web sources and news partners
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc BDR
CEOჰავიერ ჯეი როდრიგეს
Employees78 ათ.
Founded1992
Headquartersდენვერი, კოლორადოს შტატი, ამერიკის შეერთებული შტატები
SectorHealth care provider
Websitedavita.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
3,42 მლრდ.
3,62 მლრდ.
3,42 მლრდ.
3,55 მლრდ.
Cost of goods sold
2,33 მლრდ.
2,41 მლრდ.
2,34 მლრდ.
2,39 მლრდ.
Cost of revenue
2,33 მლრდ.
2,41 მლრდ.
2,34 მლრდ.
2,39 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402,67 მლნ.
472,36 მლნ.
421,91 მლნ.
423,46 მლნ.
Operating expense
580,16 მლნ.
659,06 მლნ.
599,74 მლნ.
591,27 მლნ.
Total operating expenses
2,91 მლრდ.
3,07 მლრდ.
2,94 მლრდ.
2,98 მლრდ.
Operating income
507,30 მლნ.
551,20 მლნ.
473,55 მლნ.
570,82 მლნ.
Other non operating income
-17,26 მლნ.
-21,03 მლნ.
639,00 ათ.
4,47 მლნ.
EBT including unusual items
308,80 მლნ.
382,76 მლნ.
341,23 მლნ.
435,01 მლნ.
EBT excluding unusual items
351,55 მლნ.
391,79 მლნ.
341,23 მლნ.
437,04 მლნ.
Income tax expense
68,55 მლნ.
76,73 მლნ.
66,20 მლნ.
91,79 მლნ.
Effective tax rate
22,20%
20,05%
19,40%
21,10%
Other operating expenses
-
-
-
-
Net income
150,33 მლნ.
234,22 მლნ.
197,53 მლნ.
265,40 მლნ.
Net profit margin
4,40%
6,47%
5,78%
7,47%
Earnings per share
2,51
3,40
2,87
4,02
Interest and investment income
-
-
-
-
Interest expense
-148,66 მლნ.
-148,25 მლნ.
-141,30 მლნ.
-146,42 მლნ.
Net interest expenses
-148,66 მლნ.
-148,25 მლნ.
-141,30 მლნ.
-146,42 მლნ.
Depreciation and amortization charges
177,49 მლნ.
186,70 მლნ.
177,83 მლნ.
167,81 მლნ.
EBITDA
684,80 მლნ.
737,91 მლნ.
651,38 მლნ.
738,62 მლნ.
Gain or loss from assets sale
-
-17,55 მლნ.
-
-
AI content may include mistakes. Learn more
Google აპები